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 Lung cancer is the leading cause of death among Vietnamese people and can be divided into two major 
groups: small cell lung cancer (SCLC), and non-small cell lung cancer (NSCLC). It is estimated that 85% of 
patients was diagnosed as NSCLC. Therapy drugs that targeted lung cancer tumors with the epidermal growth 
factor receptor (EGFR) may initially provide benefit, but over time tumors can develop resistance. The recent 
discovery of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) has provided a new target for the theurapeutic 
agents in non-small cell lung cancer treatment. In our study, homoisopogon A, a new compound isolated from 
the tubers of Ophiopogon japonicus (Mach mon, in Vietnamese) effectively showed the cytotoxic activity to 
the EGFR and TKI-resistant NSCLC cell lines including human lung carcinoma A549, human lung 
adenocarcinoma NCI-H1975 and human lung adenocarcinoma NCI-H1650. The IC50 values of homoisopogon 
A against A549, NCI-H1975 and NCI-H1650 were determined as 6.26, 19.51, and 24.66 µM, respectively. 
Preliminary study on the mechanism of action using flow cytometry analysis was performed. Homoisopogon A 
treatment of A549 cells at concentration of 25 µM generated apoptosis in 27.5% of cells (7% early apoptosis 
and 20.5% late apoptosis) after 24h of treatment. The effect increased significantly at the concentration of 50 
µM, the homoisoflavanone generated apoptosis in 83.8% of cells (23.5% early apoptosis and 60.3% late 
apoptosis). Treatment with homoisopogon A for 48h also resulted in typical apoptotic morphological changes 
in A549 cells under microscopic observation. The results strongly suggested that homoisopogon A induces 
apoptosis in EGFR and TKI-resistant-A549 cells, thus resulting in the cytotoxicity. 
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INTRODUCTION 
 Lung cancer is the most common cause of 
cancer death in Vietnam and the second 
deathliest cancers after liver cancer (Bernard et 
al., 2014). Accordingly, 22,000 Vietnamese 
people are diagnosed with lung cancer yearly 
while 19,500 people succumb to the disease 
every year. Approximately 98% of lung cancers 
are carcinoma, or tumors derived from 
transformed cells of epithelial lineage (Gadepalli 
et al., 2014). Recently, nearly four dozen 
different histopathological variants of lung 
carcinoma are recognized (Travis et al., 1995). 
Lung cancer can be classified into two major 
types including small cell lung cancer (SCLC) 
and non-small cell lung cancer (NSCLC). It is 
estimated that 85 percent of all lung cancers are 
non-small cell, and approximately 75 percent of 
these are metastatic, or advanced, at diagnosis. 
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Squamous cell carcinoma, adenocarcinoma, and 
large cell carcinoma are subtypes of non-small 
cell lung cancer (Travis I 2004). The pivotal role 
in tumorigenesis of the epidermal growth factor 
receptor (EGFR) was discovered recently. 
Accordingly, the EGFR-tyrosine kinase 
inhibitors (EGFR-TKIs) are considered to be an 
emerging class of targeted therapeutic agents in 
NSCLC treatment (Milovancev, 2015). Although 
most EGFR-mutant NSCLCs initially respond to 
EGFR-tyrosine kinase inhibitors such as 
Gefitinib (Iressa) and erlotinib (Tarceva), the 
vast majority of these tumors ultimately become 
resistant to the drug treatment (Raz et al., 2006; 
Bencardino et al., 2011). Currently, EGFR-TKIs 
are known to contribute considerably to the 
extension of progression-free survival in 
prognosis for NSCLC. 
 In the course to search for anticancer agents, a 
new homoisoflavanone isolated from the tubers of 
Ophiopogon japonicus, homoisopogon A, was found 
to exhibit the potent cytotoxicity against various 
cancer cell lines including human lung 
adenocarcinoma LU-1, human epidermoid 
carcinoma KB and human melanoma SK-Mel-2 cell 
lines (Dang et al., 2017). This finding suggests 
homoisopogon A may be a potential therapeutic 
agent targeted on NSCLC. In this paper, the 
cytotoxic activity of this compound on different 
NSCLC cell lines A549, NCI-H1975, and NCI-
H1650 was evaluated.  The preliminary investigation 
was conducted to find out whether homoisopogon A 
is able to induce apoptosis or necrosis in A549 cells 
using a flow cytometry method. 
MATERIALS AND METHODS 
Isolation of Homoisopogon A 
 Homoisopogon A was isolated from the roots of 
Ophiopogon japonicus as previously described 
(Dang et al, 2017). Its chemical structure is shown in 
Figure 1. Homoisopogon A as obtained as 
amorphous yellow powder, it showed a molecular 
peak at m/z 345.1 [M + H]+. The purity of 
homoisopogon A was checked by 1H-NMR and 13C-
NMR. The compound was solubilized in dimethyl 
sulfoxide (DMSO) and used as a final concentration 
of less than 0.05% DMSO. 
 
Figure 1. Structure of Homoisopogon A. 
Cell lines and cell culture 
The cancer cell lines A549 (Human lung 
carcinoma), NCI-H1975 (Human lung 
adenocarcinoma), NCI-H1650 (Human lung 
adenocarcinoma) were kindly provided by Prof. Jeong-
Hyung Lee, Department of Biochemistry, College of 
Natural Sciences, Kangwon National University, 
Korea. The cells were cultured at 37 °C in RMPI 1640 
or medium supplemented with 10% fetal bovine serum 
(FBS), 100 U/ml penicillin, and 100 µg/ml 
streptomycin in a 5% CO2 incubator. Cells between 5 
and 20 passages were used for the assays.  
Cell proliferation assay 
 An MTT [3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyltetrazolium bromide] assay was used to 
measure the viability of cells after extract treatment. 
Cells were seeded in 96-well plates at a density of 
2.0×105 cells/ml. Cells were treated with various 
concentrations of the compound (0.3, 1, 3, 10, and 30 
µM) and then incubated at 37°C for 48 h. Cells were 
subsequently incubated at 37°C with MTT (0.5 mg/ml) 
for 4 h. After removal of supernatant, formazan crystals 
were dissolved in isopropanol and the optical density 
was measured at 570 nm (Binh et al., 2015). 
Camptothecin was used as a positive control. 
Morphological changes 
 A549 cells were treated with different 
concentrations (1, 10, and 30 µM) of homoisopogon 
A for 48 hours. The morphological changes of the 
A549 cells were observed using an inverted light 
microscope (Olympus CKX 41, Japan)  
Flow cytometry analysis 
 Apoptosis is assessed by flow cytometry using a 
FACS equipment (BD Biosciences, USA). The FITC 
Annexin V Apoptosis Detection Kit I (BD 
Pharmingen, USA) was used for the assessment. 
Annexin-V binds to phosphatidylserine (PS) that was 
externalized early in the process of apoptosis can be 
detected by the FACS system. A549 cells were 
plated in 6 cm plates and incubated in 2 mL of 
medium for 24 h. After the incubation, cells were 
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treated with homoisopogon A at two concentrations 
25 µM and 50 µM and incubated for 24 h. Cells were 
then collected, washed once with PBS, and 
resuspended in the 1X Binding buffer at a density of 
1 × 106 cells/ml. FITC Annexin V and PI was added 
and incubated for 15 min, at room temperature, in 
darkness. The cells were analyzed in the FACS 
equipment within 1 hour. 
Statistics 
 Results are given as the mean standard error for 
the mean (SEM). IC50 values and statistical analyses 
were performed with GraphPad Prism 6.0 Software 
(La Jolla, CA, USA). 
RESULTS AND DISCUSSION 
 In the past few years, the discovery of the 
pivotal role in tumorigenesis of the epidermal growth 
factor receptor (EGFR) provided a new class of 
targeted therapeutic agents: the EGFR-tyrosine 
kinase inhibitors (EGFR-TKIs) (Milovancev et al., 
2015). Interestingly, homoisopogon A exhibited 
strong cytotoxic effect to the wild type of EGFR-
TKI-resistant A549 cells (IC50 = 6.26 ± 0.79 µM), 
which was more effective than to the positive 
control, camptothecin (IC50 = 12.42 ± 0.56 µM). 
Also, homoisopogon A exhibited the strong 
cytotoxicity toward two other cell lines NCI-H1975 
and NCI-H1650. The cytotoxicity of 
homoisoflavonoids has been reported elsewhere (Lin 
et al., 2014; Alali et al., 2015), however, this is the 
first report on the effects of the homoisoflavanone on 
different EGFR/TKI-resistant lung cancer cell lines.
  
 Remarkably, homoisopogon A seems to be more 
specific on the wild type of EGFR and TKI-
resistance than the mutation ones. This finding may 
provide a new agent targeting on the wild type of 
EGFR/TKI-resistant cell lines. We continued to 
further investigate the mechanism of action of this 
compound in A549 cells.  
 
 
A: 0 µM 
 
B: 1 µM 
 
C: 10 µM  D: 30 µM 
Figure 2. Effects of homoisopogon A at different concentration (A: 0 µM; B 1 µM, C: 10 µM; D: 30 µM) on the morphological 
changes of A549 cells after 48h treatment. 
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Table 1. Cytotoxic effect of homoisopogon A towards NSCLC cell lines (IC50 ± SD, µM). 
 Wild type of EGFR and TKI-
resistance 
Mutation of EGFR and TKI-resistance 
Cell lines A549 H1650 H1975 
Homoisopogon A 6.26 ± 0.79 24.66 ± 0.09 19.51 ± 0.03 
Camptothecina 12.42 ± 0.56 8.23 ± 0.56 14.52 ± 0.56 
a positive control. All experiments were carried out in triplicated. 
	
Figure 3. Apoptotic effect of homoisopogon A in A549 cells analyzed with Annexin V-FTIC/PI assay after 24h treatment. 
 
 Cell death by apoptosis usually result in the 
morphological changes. The most significant 
characteristic changes are cell shrinkage, nuclear 
condensation and membrane blebbing with the 
formation of apoptotic bodies. Figure 2 shows the 
growth of A549 cells was inhibited by the treatment 
with homoisopogon A for 48 hours. The number of 
cells decreased and cell debris increased in the 
proportion with the increase of drug concentration. 
Cells exhibited the typical apoptotic morphological 
changes including both cell shrinkage, nuclear 
condensation  and membrane blebbing (Fig. 2C, D). 
 Apoptosis and necrosis are the two major types 
of cell death with different morphological 
characteristics (Farber, 1994). We next investigated 
whether necrosis or apoptosis is involved in the 
mechanism of action of homoisoflavone A in the 
EGFR-TKI-resistant A549 cells. FACS analysis 
using annexin V-FITC staining and PI accumulation 
was employed to differentiate early apoptotic cells 
(annexin V positive and PI negative) from necrotic 
or late apoptotic cells (annexin V positive and PI 
positive). Interestingly, homoisopogon A induced 
apoptosis potently (Fig. 3A) at two investigated 
concentrations after 24h of treatment. 
Homoisopogon A treatment of A549 cells at 
concentration of 25 µM generated apoptosis in 
27.5% of cells (7% early apoptosis and 20.5% late 
apoptosis). The effect increased significantly at the 
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generated apoptosis in 83.8% of cells (23.5% early 
apoptosis and 60.3% late apoptosis) (Fig. 3B). The 
movement of cells strongly suggested the cells 
underwent the apoptosis by treatment of 
homoisopogon A. 
 The growth factor EGF is one of the major 
promoters of migration and mobility in cancer cells. 
It regulates the cell proliferation, growth and 
differentiation by binding to its receptor EGFR. Two 
important cascades that can be activated by EGF are 
PI3K/Akt and MAPK/ERK pathways. Inhibition of 
the PI3/Akt pathway induces cell apoptosis in most 
cancers (Mao et al., 2016). Whereas, the 
MAPK/ERK pathway plays a role in linking the 
extracellular signals to control the cellular process 
such as cell migration, proliferation, and apoptosis 
(Dhillon et al., 2007). Inhibition of EGFR, therefore, 
may suppress the EGF activation and result in the 
apoptosis of the cancer cells. Our preliminary 
findings indicated that the homoisoflavanone might 
have potential as an anti-cancer agent, and further 
studies are being performed to clarify its mode of 
action. 
CONCLUSIONS 
Our study indicated that homoisopogon A isolated 
from Ophiopogon japonicus showed the cytotoxicity 
to three lung cancer cell lines including A549, NCI-
H1975 and NCI-H1650. Preliminary study on the 
mechanism of action revealed that homoisopogon A 
induces apoptosis in A549 cells at two different 
concentrations after 24h of treatment. 
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